The main goal of drug delivery research is to develop formulations that fulfil the therapeutic needs related to particular pathological conditions. Technological advancements have brought many new innovative drug delivery systems into commercial circulation. Biodegradable and non biodegradable biocompatible microparticulate systems have shown clear advantages by controlled drug release and drug targeting for parenteral and oral drug delivery.

The production of structured microparticles via spray drying is of interest due to the fact that the prepared particles exhibit unique properties that permit their use in various fields. Tramadol-Hcl is a nonsteroidal anti-inflammatory drugs (NSAIDs) drug widely formulated in microspheres and microcapsules for pharmaceutical controlled release systems owing to its short half- life, the irritation in the gastrointestinal mucosa, and its unpleasant taste. The drug is freely water soluble and hence judicious selection of release retarding excipients is necessary to achieve a constant *in vivo* input rate of the drug. The preparation of tramadol microspheres by spray-drying is possible only under certain experimental conditions, and it is affected by the polymer type and by drug--polymer ratio. The aim of the present study was to study the influence of the spray-drying technological parameters on the physicochemical properties of tramadol microspheres and on the yield of microparticles and encapsulation efficiency. Spray dryer parameters that we have changed are Inlet temperature, aspirator capacity, pump capacity and feed pump solution rate. We have concluded from our results that the inlet temperature is important parameter for both particle dimensions and recovery; it must be compatible with the material (drug and polymer) and solvent utilized. Air aspirator significantly influences the transformation of nebulized droplets in solid particles. The peristaltic pump influences the time and efficacy of the drying process as well as the particle dimensions.

Subjects and Methods {#sec1-1}
====================

Materials {#sec2-1}
---------

Tramadol-HCL was gifted by Sun Pharmaceuticals PVT. LTD Eudragit^®^ RS 100 (RS) and Eudragit^®^ RL 100 (RL) were kindly provided by Evonik Pharma Polymers GmbH (Mumbai).Dichloromethane and ethanol were of analytical grade.

Microsphere preparation {#sec2-2}
-----------------------

Tramadol Hcl microspheres were prepared using a mini spray dryer (LU222, Labultima Pvt. Ltd, Mumbai), equipped with the high-performance cyclone. Tramadol Hcl microparticles were prepared by spraying a 2% (wt/vol) solution of drug and polymer in 100 ml solvent (50 mlCH~2~Cl~2+~50ml Ethanol), obtained by dissolving 100 mg of Tramadol and 750?mg of Eudragit mg of Eudragit^®^ polymers which contain 375 mg of both RS and RL, 150 mg Aerosil) All spray-drying parameters used are reported in [Table 1](#T1){ref-type="table"}. This formulation was produced three times for verifying the method reproducibility. To prove the influence of the manufacturing parameters on microsphere characteristics, air aspirator or peristaltic pump capacity or drying temperature was changed: The formulations obtained and the respective spray-drying conditions used are listed in [Table 1](#T1){ref-type="table"}. Formulations B and C were produced by spraying the feed solution previously described, setting the air aspirator capacity at 40% respectively; three different formulations (D--F) were produced decreasing the peristaltic pump capacity. The inlet temperature was reduced from 50 to 40°C for preparing the G formulation. On the basis of the results obtained from the *in vitro* characterization of A--G, a new spray-dried microparticle batch, H, was prepared choosing the following parameters: The heating was set at 40°C and the aspirator and pump capacity at 40% and 4%, wth feed pump rate 2.5 ml/min respectively \[[Table 1](#T1){ref-type="table"}\].

###### 

Spray-drying conditions used for preparing the tramadol formulations
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Microsphere characterization {#sec2-3}
----------------------------

After formulation, the microspheres were stored for 24 h in a desiccators at 12% relative humidity (RH) and 20±1°C. They were then characterized by DSC, XRD, % yield, drug content, encapsulation efficiency, particle size and particle size distribution by SEM analysis and morphological properties during physical stability studies.

Yield of production {#sec2-4}
-------------------

Dried microspheres were accurately weighed, and considering the total amount of drug and polymers used for preparing the feed solution, the yield of production (YP) was calculated, as a percentage, using the following equation:
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where *MC* stands for the amount of produced microspheres and (RS + RL + T) for the sum of the amounts of two types of Eudragit^®^ and tramadol solubilized for the preparation of microparticles.

Encapsulation efficiency determination {#sec2-5}
--------------------------------------

To determine the exact amount of tramadol encapsulated into RS/RL matrix, weighed amount of microspheres were solubilized in 100 mL ethanol. The UV absorbance of the solution was measured using a Schimadzu UV-Visible spectrophotometer, model at 271 nm. These resulting values were interpolated at the calibration curve of tramadol in ethanol, elaborated earlier.

EE(%) = T~r~/T~t~ × 100

where *T~r~* is the amount (grams) of tramadol microspheres, and *T~t~* is the grams of tramadol theoretically the polymeric matrix.

Particle size and particle size distribution analyses {#sec2-6}
-----------------------------------------------------

The mean diameter and size distribution of microsphere were determined by laser diffraction (Coulter LS 100Q Laser Sizer, Beckman Coulter, Miami, FL, USA). A sample of microspheres (5.0 mg) was suspended in 0.5 mL volatile silicone fluid and sonicated in ultrasound bath for 5 s before particle size analysis. Because a Gaussian-like distribution of particle size was observed, the particle size is described by the volume/surface mean diameter (d~vs~) and the standard deviation (SD), whereas microparticle size distribution is expressed as SPAN Index (SI) calculated applying the following equation: SI = d~90~ -- d~10~/d~90~ where *d*~10~, *d*~50~, and *d*~90~indicate the volume percentage of particles (10, 50, and 90% respectively) having a mean diameter lower than the obtained value.

Morphological analysis {#sec2-7}
----------------------

Microsphere morphology was studied by scanning electron microscopy (SEM) (ISI-DS 130 Scanning Electron Microscope, Akashi Beam Technology Corporation, Tokyo, Japan).Completely dried microspheres were mounted on aluminium stubs using double-sided adhesive tape. They were then gold sputtered and analyzed with accelerating voltage of 20 kV. The resulting images were photographed.

Differential Scanning Calorimetric Studies {#sec1-2}
==========================================

The thermal behavior of tramadol in A and C formulations was determined using differential scanning calorimeter (DSC) (DSC Q100 V9.0, TA Instrument, New Castle, DE, USA). As a comparison, the thermal behavior of pure drug (raw material), polymers, and blank microspheres (prepared using a mixture of RS and RL 100) was studied. Samples of 5 mg were scanned in crimped sealed aluminum pans, under static air atmosphere. An empty pan was used as reference. The heating rate was 10°C/min, and the temperature interval used was --40 to 250°C.

Statistical analysis {#sec2-8}
--------------------

Statistical analysis was performed using Softwar. Unpaired *t*-test was applied to test the significance of the effect of each spray-drying parameter on the yield of production, the drug content, and the encapsulation efficiency, and particle size of microsphere formulations. The significant level was set at *P*\<0.05.

Results and Discussion {#sec1-3}
======================

Tramadol microspheres can be produced by spray-drying technique using Eudragit^®^ RS 100 and RL 100 as polymers. The technological parameters employed for A preparation \[[Table 1](#T1){ref-type="table"}\] allow to obtain microspheres with good yield of production (59.4±1.5%); drug content (30.2±0.8%) and encapsulation efficiency values (81.65±0.89%).

DSC analysis {#sec2-9}
------------

From DSC study it was shown that drug shows sharp peak around 180°C which shows melting point of drug, while peak at 180°C was disappear in prepared formulation which indicates that interaction between drug and polymer has taken place.

XRD study and SEM analysis {#sec2-10}
--------------------------

The X-ray diffraction spectra were recorded for Tramadol Hcl microspheres for investigating the crystallanity of the drug in the polymeric microspheres \[Figure\]. The X-ray diffractogram showed sharp peaks at diffraction angle 18.95° depicting a typical crystalline pattern. Drug loaded microspheres showed peaks, but of low intensity, indicating that some amount of drug was converted to amorphous form. SEM analysis shows that the decrease of aspirator capacity does not influence particle morphology: B and C microspheres are spherical but the smallest particles appear partially sticking to each other.

Particle size and particle size distribution {#sec2-11}
--------------------------------------------

The microspheres have 8.7±2.1 μm dvs and narrow size distribution as indicated by SI value (1.42).

The reduction to 10% of the air aspirator capacity determines, in case of D formulation, a significant decrease of production yield (*P*=0.013) caused by the loss of dried particles inside the nebulization chamber. Drug content and encapsulation efficiency of B microspheres (*P*\<0.05) decrease. B and C microspheres are spherical but the smallest particles appear partially sticking to each other. Compared with A, the use of 8% pump capacity (D) causes a significant increase of the yield production and the particle size distribution, as expressed by the highest SI (1.52), whereas applying 2% pump ratio (F) the DC and EE slightly decrease (*P*\<0.05). As the temperature reduction increases the particle size, the percentage of particles mainly consisting of polymers sucked up from the aspirator decreases. Because the feed rate of polymeric solution could influence the efficacy of drying process and particle size. Three Eudragit^®^ microparticle formulations, called D, E, and F, were produced changing the peristaltic pump capacity to 8, 4, and 2%, respectively. Compared with A, the use of 8% pump (D) causes a significant increase of the yield production and the particle size distribution, as expressed by the highest SI (1.52), whereas applying 2% pump ratio (F) the DC and EE slightly decrease (*P*\<0.05) \[[Table 2](#T2){ref-type="table"}\].

###### 

Characterization of microsphere formulations
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The feed rate does not influence significantly the particle dimensions (*P*\>0.05), even if the lowest pump capacity (2%) produces the smallest particles (6.87 μm): No differences are observed among D--F and A. This could be attributed to the low viscosity of feed solutions and to the high volatility of the solvent used. The reduction of heating from 50 to 40°C determines a significant increase (*P*=0.03) of microsphere recovery (YP of G is about 65.43%), As the temperature reduction increases the particle size, the percentage of particles mainly consisting of polymers sucked up from the aspirator decreases. The dimensions and the shape of G are similar to those of A microspheres. The H formulation was prepared changing, with respect to A at the same time heating (40°C), aspirator (40%) and pump capacities (4%). In fact the use of a temperature of 40°C allows to obtain the highest Y*P* value, and the aspirator at 40% of its capacity shows DC and EE% significantly different from A; finally, the pump capacity of 4% was chosen for controlling the outlet temperature. The characterization shows that by these parameters it is possible to produce microspheres with similar properties in terms of yield, drug content, size, and morphology than A.

Briefly the *in vitro* characterization demonstrates that G shows the highest value of yield of production compared with the other formulations; all the microspheres are produced with good EE% 76-95%. All microparticles present *d*~vs~ values lower than A, but in any case they range from 6.9 to 7.8 μm; no differences are revealed in size distribution profiles: SI data are between 1.42 and 1.52.

Physical Stability Studies {#sec1-4}
==========================

The stability tests were carried out to evaluate the possible variations of microparticle morphology and dimension both after drying and after storage. After production, the microspheres were dried for 24 h in oven at 30°C; the microspheres were then studied by SEM As shown in \[Figure 5\], after the thermal treatment at 30°C, the A microspheres loose their integrity and sphericity: Mainly the small particles are inclined to merge and make aggregates

Conclusion {#sec1-5}
==========

Tramadol microspheres based on Eudragit^®^ RL and RS blend can be prepared by spray-drying with good yields of production, high drug content, and encapsulation efficiency using appropriate spray-drying technological parameters. All formulations have good morphological and dimensional characteristics: Spherical shape, smooth surface, and narrow size distribution. Thus, RS and RL 100 used as mixture and in the drug-to-polymer ratio of 1:3 are suitable to produce microspheres containing tramadol, by spray-drying. A large choice of manufacturing parameters can be used to obtain microparticle but specific temperature of drying and way of storage are required.
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